#United States #New York #Class Action #Pomerantz #Zynex

Investor Alert: Class Action Lawsuit Against Zynex, Inc.

Pomerantz LLP has issued a notice to investors regarding a class action lawsuit filed against Zynex, Inc. (NASDAQ: ZYXI). This lawsuit is particularly relevant for investors who have experienced losses related to their investments in Zynex due to alleged fraudulent activities by the company.

Overview of the Lawsuit

The class action centers on the claims that Zynex and certain executive officers may have engaged in securities fraud and other unlawful business practices, creating significant uncertainty about the company's compliance with regulatory norms. Investors who purchased Zynex securities during the specified class period are encouraged to consider participating in the lawsuit, particularly those who feel they have suffered as a direct result of the alleged misconduct.

Important Dates for Investors

The deadline for filing to become a Lead Plaintiff in the lawsuit is May 19, 2025. Investors should reach out to Pomerantz LLP to discuss their eligibility and ensure their voices are heard in this pivotal legal matter. They can contact Danielle Peyton directly at [email protected] or call the office toll-free at 888.4-POMLAW, ext. 7980.

Background on the Allegations

Recent revelations have exacerbated the situation for Zynex and its shareholders. A report aired by the medical journal, STAT, on June 4, 2024, brought to light serious concerns regarding Zynex's business practices. The report detailed an alleged